Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 12 — International Consensus Conference on Outcome Measures in Rheumatology, Budapest, Hungary, May 7–11, 2014

Validation of the OMERACT Magnetic Resonance Imaging Joint Space Narrowing Score for the Wrist in a Multireader Longitudinal Trial

Daniel Glinatsi, Siri Lillegraven, Espen A. Haavardsholm, Iris Eshed, Philip G. Conaghan, Charles Peterfy, Frédérique Gandjbakhch, Paul Bird, Pernille Bøyesen, Uffe M. Døhn, Harry K. Genant and Mikkel Østergaard
The Journal of Rheumatology December 2015, 42 (12) 2480-2485; DOI: https://doi.org/10.3899/jrheum.141009
Daniel Glinatsi
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, University of Copenhagen and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, University of Oslo, Oslo, Norway; Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, UK; Spire Sciences Inc., Boca Raton, Florida, USA; Department of Rheumatology, Pitié Salpêtrière Hospital, APHP, Université Paris 6-UPMC, Paris, France; University of New South Wales, Sydney, Australia; Medicine and Orthopedics, University of California, San Francisco, and Synarc Inc., San Francisco, California, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: daniel.glinatsi@gmail.com
Siri Lillegraven
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Espen A. Haavardsholm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iris Eshed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip G. Conaghan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Peterfy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédérique Gandjbakhch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Bird
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pernille Bøyesen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uffe M. Døhn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harry K. Genant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikkel Østergaard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Prevalence and mean scores of JSN (status and change), per individual joint space. The prevalence of patients with a score > 0 at baseline (A) and for change scores (B) is shown at each individual joint site. Mean scores at baseline and followup (C) and for change scores (D) are means of the 8 reads (2 reads by each of the 4 readers). JSN: joint space narrowing; CMC: carpometacarpal; TRM: trapezium; TRD: trapezoid; CAP: capitate; HAM: hamate; SCA: scaphoid; LUN: lunate; TRI: triquetrum; RAD: radius.

Tables

  • Figures
    • View popup
    Table 1.

    Baseline characteristics of the 20 patients with rheumatoid arthritis included in the exercise.

    Female, n (%)15 (75)
    Age, yrs, median (25th and 75th percentile)55 (41;63)
    Disease duration, days, median (25th and 75th percentile)87 (36;136)
    IgM RF positivity, n (%)9 (45)
    Anti-CCP positivity, n (%)12 (60)
    DAS28, median (25th and 75th percentile)3.78 (3.30;4.72)
    ESR, mm/h, median (25th and 75th percentile)12 (10;21)
    28-joint swollen joint count, median (25th and 75th percentile)5.5 (4;10)
    • IgM RF: immunoglobulin M rheumatoid factor; CCP: cyclic citrullinated protein; DAS: Disease Activity Score; ESR: erythrocyte sedimentation rate.

    • View popup
    Table 2.

    Intrareader and interreader intraclass correlation coefficients (ICC) and smallest detectable change (SDC).

    IntrareaderInterreader
    Reader 1Reader 2Reader 3Reader 4
    ICC
      Baseline total score (95% CI)0.89 (0.69 to 0.96)0.79 (0.51 to 0.91)0.52 (0.11 to 0.78)0.96 (0.90 to 0.98)0.36 (−0.03 to 0.68)
      Total change score (95% CI)0.41 (−0.02 to 0.72)0.93 (0.83 to 0.97)0.93 (0.83 to 0.97)0.95 (0.87 to 0.98)0.93 (0.87 to 0.97)
    SDC (percentage of maximum score observed)
      Total score6.75 (0.31)2.56 (0.14)2.34 (0.09)3.18 (0.12)2.88 (0.03)
      CMC10.30 (0.15)0.31 (0.15)0.57 (0.38)0.51 (0.34)0.36 (0.05)
      CMC20.31 (0.31)0.31 (0.31)0.68 (0.34)0.55 (0.36)0.29 (0.05)
      CMC30.43 (0.21)0.51 (0.34)0.45 (0.30)0.62 (0.41)0.35 (0.05)
      CMC40.62 (0.41)0.68 (0.68)0.93 (0.93)0.57 (0.38)0.26 (0.05)
      CMC50.62 (1.24)0.31 (0.31)0.00 (NP*)0.68 (0.68)0.26 (0.11)
      TRM-TRD0.43 (0.85)0.00 (NP*)0.00 (NP*)0.00 (NP*)0.08 (0.15)
      TRD-CAP0.73 (0.73)0.84 (0.56)0.76 (0.51)0.43 (0.43)0.33 (0.07)
      CAP-HAM0.31 (0.15)0.62 (0.62)0.62 (0.25)0.43 (0.28)0.32 (0.05)
      TRM-SCA0.77 (0.51)0.55 (0.27)0.55 (0.22)0.78 (0.31)0.49 (0.06)
      TRD-SCA0.62 (0.62)0.73 (0.48)0.31 (0.21)0.55 (0.55)0.30 (0.06)
      CAP-SCA0.55 (0.27)0.31 (0.21)0.43 (0.21)0.51 (0.17)0.39 (0.05)
      CAP-LUN0.43 (0.21)0.31 (0.15)0.71 (0.35)0.45 (0.22)0.33 (0.04)
      HAM-TRI0.00 (0.00)0.62 (0.41)0.51 (0.20)0.68 (0.27)0.32 (0.04)
      SCA-LUN0.71 (0.28)0.31 (0.15)0.62 (0.21)0.62 (0.25)0.26 (0.03)
      LUN-TRI0.43 (0.21)0.55 (0.27)0.62 (0.21)0.55 (0.22)0.45 (0.05)
      RAD-SCA0.89 (0.89)0.55 (0.55)0.31 (0.31)0.31 (0.15)0.31 (0.06)
      RAD-LUN0.64 (0.32)0.64 (0.25)0.43 (0.17)0.45 (0.15)0.27 (0.03)
    • ↵* NP: Not possible to calculate because of zero variance. Intrareader agreement is expressed as single measure ICC and interreader agreement as average measure ICC with a 95% CI. An ICC ≥ 0.50 is considered good and an ICC ≥ 0.80 is considered very good. SDC is calculated for intrareader and interreader change scores and is also expressed as the percentage of the maximal score observed by the reader. Interreader agreement is calculated by using the mean score of the 2 readings performed by each reader on a single timepoint. CMC: carpometacarpal; TRM: trapezium; TRD: trapezoid; CAP: capitate; HAM: hamate; SCA: scaphoid; LUN: lunate; TRI: triquetrum; RAD: radius.

    • View popup
    Table 3.

    Percentage of exact agreement (PEA) and close agreement (PCA) for JSN assessment in each individual joint space.

    Intrareader BaselineIntrareader ChangeInterreader BaselineInterreader Change
    Mean PEAMean PCAMean PEAMean PCAPEAPCAPEAPCA
    CMC173.8100.087.5100.05.075.045.0100.0
    CMC277.5100.092.598.80.040.055.0100.0
    CMC366.395.088.8100.00.060.050.085.0
    CMC452.596.376.396.30.075.055.095.0
    CMC561.3100.093.8100.05.070.055.0100.0
    TRM-TRD92.597.597.5100.065.0100.090.0100.0
    TRD-CAP58.891.370.098.815.050.035.095.0
    CAP-HAM60.898.787.398.70.050.060.095.0
    TRM-SCA73.8100.081.3100.015.060.030.070.0
    TRD-SCA70.095.084.8100.00.045.035.090.0
    CAP-SCA78.8100.090.0100.010.085.055.085.0
    CAP-LUN80.0100.091.397.55.080.060.095.0
    HAM-TRI79.7100.087.3100.020.085.060.090.0
    SCA-LUN82.5100.090.097.545.095.045.0100.0
    LUN-TRI73.8100.083.8100.015.075.040.075.0
    RAD-SCA77.5100.087.598.815.085.045.0100.0
    RAD-LUN82.5100.085.0100.030.090.060.095.0
    All joints (mean)74.196.086.799.214.471.851.592.4
    • Intrareader percentage of exact agreement (PEA) expresses the percentage of the patients receiving the same score twice by a single reader, and intrareader percentage of close agreement (PCA) is the percentage of the patients where the 2 readings differ no more than 1.0 in score. Intrareader PEA and PCA are presented as the mean of the 4 readers. Interreader PEA expresses the percentage of the patients receiving the same score by all 4 readers, and the interreader PCA is the percentage of the patients where the difference between the minimum and maximum score is ≤ 1.0. CMC: carpometacarpal; TRM: trapezium; TRD: trapezoid; CAP: capitate; HAM: hamate; SCA: scaphoid; LUN: lunate; TRI: triquetrum; RAD: radius.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 42, Issue 12
1 Dec 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Validation of the OMERACT Magnetic Resonance Imaging Joint Space Narrowing Score for the Wrist in a Multireader Longitudinal Trial
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Validation of the OMERACT Magnetic Resonance Imaging Joint Space Narrowing Score for the Wrist in a Multireader Longitudinal Trial
Daniel Glinatsi, Siri Lillegraven, Espen A. Haavardsholm, Iris Eshed, Philip G. Conaghan, Charles Peterfy, Frédérique Gandjbakhch, Paul Bird, Pernille Bøyesen, Uffe M. Døhn, Harry K. Genant, Mikkel Østergaard
The Journal of Rheumatology Dec 2015, 42 (12) 2480-2485; DOI: 10.3899/jrheum.141009

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Validation of the OMERACT Magnetic Resonance Imaging Joint Space Narrowing Score for the Wrist in a Multireader Longitudinal Trial
Daniel Glinatsi, Siri Lillegraven, Espen A. Haavardsholm, Iris Eshed, Philip G. Conaghan, Charles Peterfy, Frédérique Gandjbakhch, Paul Bird, Pernille Bøyesen, Uffe M. Døhn, Harry K. Genant, Mikkel Østergaard
The Journal of Rheumatology Dec 2015, 42 (12) 2480-2485; DOI: 10.3899/jrheum.141009
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Keywords

OMERACT
RAMRIS
JOINT SPACE NARROWING
RHEUMATOID ARTHRITIS
MAGNETIC RESONANCE IMAGING

Related Articles

Cited By...

More in this TOC Section

OMERACT 12 — International Consensus Conference on Outcome Measures in Rheumatology, Budapest, Hungary, May 7–11, 2014

  • Minimal Clinically Important Difference as Applied in Rheumatology: An OMERACT Rasch Working Group Systematic Review and Critique
  • Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter — Determining Validation Requirements
  • Development of Image Overlay and Knowledge Transfer Module Technologies Aimed at Enhancing Feasibility and External Validation of Magnetic Resonance Imaging-based Scoring Systems
Show more OMERACT 12 — International Consensus Conference on Outcome Measures in Rheumatology, Budapest, Hungary, May 7–11, 2014

Special Interest Groups I

  • Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative
  • Outcome Measures in Polymyalgia Rheumatica. A Systematic Review
Show more Special Interest Groups I

Similar Articles

Keywords

  • OMERACT
  • RAMRIS
  • JOINT SPACE NARROWING
  • rheumatoid arthritis
  • magnetic resonance imaging

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire